Long-lasting analgesic effect of the psychedelic drug changa: A case report
Journal of Psychedelic Studies February 12, 2019 DOI: 10.1556/2054.2019.001 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A single patient |
| Intervention | changa |
| Keywords | Analgesic Drug Neurotransmitter systems Pharmacology |
| Citations | 13 |
| Key findings | Changa produced a long-lasting analgesic effect in the reported case. |
Abstract
Pain is the most prevalent symptom of a health condition, and it is inappropriately treated in many cases. Here, we present a case report in which we observe a long-lasting analgesic effect produced by changa, a psychedelic drug that contains the psychoactive N,N-dimethyltryptamine and ground seeds of Peganum harmala, which are rich in β-carbolines. We describe the case and offer a brief review of supportive findings. A long-lasting analgesic effect after the use of changa was reported. Possible analgesic mechanisms are discussed. We suggest that both pharmacological and non-pharmacological factors could be involved. These findings offer preliminary evidence of the analgesic effect of changa, but due to its complex pharmacological actions, involving many neurotransmitter systems, further research is needed in order to establish the specific mechanisms at work.
Citations in the library
Cited by 10
- Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review Neuroscience & Biobehavioral Reviews October 5, 2020
- Use of Psychedelics for Pain: A Scoping Review. Anesthesiology October 1, 2023
- Therapeutic Potential of Natural Psychoactive Drugs for Central Nervous System Disorders: A Perspective from Polypharmacology Current Medicinal Chemistry December 13, 2019
- Alkaloids from the entheogenic plant Peganum harmala Australian Journal of Chemistry July 17, 2023
- Psychedelic research, assisted therapy and the role of the anaesthetist: A review and insights for experimental and clinical practices. British Journal of Clinical Pharmacology December 1, 2024
and 5 more in the library
Cites 21
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator Science February 13, 2009
- Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction Current Drug Abuse Reviews January 9, 2015
and 16 more in the library